INDIAN MARKET

INTERNATIONAL BUSINESS
 
 
DR. MOREPEN GETS RESTRAINT ORDER AGAINST ‘LEMOTAB’

Doctor Morepen Limited which is 100% subsidiary of Morepen Laboratories Ltd. and had acquired the brand ‘LEMOLATE’ from M/s Yash Pharma Laboratories in the year 2002 and is manufacturing and marketing the same for last five years under Doctor  Morepen Brand.

It had come  to the knowledge of the Doctor Morepen that M/s Yash Pharma Laboratories are manufacturing/selling/trading the  unbranded LEMOTAB  and misleading the public by deceptively similar name, packaging mainly in Mumbai, Ahmedadbad, Vadodra, Patna, Kolkatta, Gauhati.

Doctor Morepen has instituted a suit for infringement against M/s Yash Pharma Laboratories and has decided to vigorously pursue and take action in respect of other medicinal products  also which are deceptively similar to their  registered trademarks.

On the application filed by Doctor Morepen, Hon’ble High Court of Delhi has  restrained  M/s Yash Pharma Laboratories from selling, offering for sale, advertising, marketing medicine under the trademark LEMOTAB or any other mark deceptively similar to the  trademark LEMOLATE till the next date of hearing .

The High Court of Delhi had also appointed  local commissioners to inspect and make inventory of the medicines bearing the mark ‘LEMOTAB’ at  the outlets from which the offending article is being sold.